The Analyst Landscape: 6 Takes On Sangamo Therapeutics
The Analyst Landscape: 6 Takes On Sangamo Therapeutics
分析師視角：對Sangamo Therapeutics的六個看法
The standing of Sangamo Therapeutics among...Analysts' ratings for Sangamo Therapeutics (NASDAQ:SGMO) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
根據6位分析師的報告，Sangamo Therapeutics（納斯達克：SGMO）在上個季度的分析師評級從看好到看淡不等。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們近期評級的彙總視圖，展示了過去30天的情緒變化，並將其與前幾個月進行了比較。
Analysts have recently evaluated Sangamo Therapeutics and provided 12-month price targets. The average target is $8.17, accompanied by a high estimate of $10.00 and a low estimate of $5.00. Observing a 29.07% increase, the current average has risen from the previous average price target of $6.33.
分析師最近評估了Sangamo Therapeutics，並提供了12個月的價格目標。平均目標爲8.17美元，最高預估爲10.00美元，最低預估爲5.00美元。觀察到29.07%的增長，目前的平均值已從之前的6.33美元的平均價格目標上升。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀：深入分析
The standing of Sangamo Therapeutics among...
通過對最近分...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間